InvestSMART

Anagenics Limited (ASX:AN1)

ALERT: Price-sensitive ASX Announcement for AN1
Current share price for AN1 : $0.007 0.001 (16.67%)+
Announcement
Release
25 Feb 2026 8:47AM
Price at Release
$0.006
Full Release
download
Summary
Anagenics Limited's Appendix 4D for the half year ended 31 December 2025 reports a significant financial turnaround. The company recorded a maiden profit of $126,685 compared to a loss of $463,929 in the previous period. Revenue and other income decreased by 10% to $2,635,660. Anagenics improved its gross profit margin by 280 basis points and reduced operating expenses by 44%, retaining 90% of its revenue following restructuring. No dividends were declared for the period. The report is based on financial statements reviewed by Connect National Audit Pty Ltd.
Key Points
  • Anagenics reported a maiden profit of $126,685 for the half year ended 31 December 2025.
  • Revenue and other income decreased by 10% to $2,635,660 compared to the previous period.
  • Gross profit margin improved by 280 basis points.
  • Operating expenses were reduced by 44%.
  • No dividends were declared during the period.
  • The financial statements were reviewed by Connect National Audit Pty Ltd.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.